Phaos Technology Holdings (Cayman) (POAS) Accumulated Expenses (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) reported Accumulated Expenses of $405231.0 for Q2 2025, up 22.61% on a YoY basis from $330495.2 in Q2 2024, and up 22.61% quarter-over-quarter from $330495.2 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) Accumulated Expenses (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) has reported Accumulated Expenses for 2 years, with the latest figure at $405231.0 in Q2 2025.
- For the quarter ending Q2 2025, Accumulated Expenses rose 22.61% year-over-year to $405231.0; the trailing twelve-month figure through Apr 2025 stood at $405231.0 (up 22.61% YoY), and the FY2025 full-year result was $414924.0, up 25.55% from the prior year.
- Accumulated Expenses for Q2 2025 stood at $405231.0, up from $330495.2 in the prior quarter.
- The five-year high for Accumulated Expenses was $405231.0 in Q2 2025, with the low at $330495.2 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 682,234.12 | 627,245.12 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 405,231.03 |
| Apr 30, 2024 | 330,495.20 |